Technology

Art

Alexandre Reuben Introduces the ATTACH Platform for Antigen-Specific T Cell Isolation

3h agoen

Read on oncodaily.com

From the article

Alexandre Reuben, Assistant Professor at MD Anderson, Director, Immunology Program at GSBS, Founder of Tenaci-T Therapeutics and Founder of ATTACHbio, shared a post on LinkedIn: “Unbiased avidity-based isolation of antigen-specific T […]

Continue reading on OncoDaily

You might also wanna read

CEDAR platform releases cancer-specific epitope prediction tools and analysis pipelines for immuno-oncology research

The article describes the Cancer Epitope Database and Analysis Resource (CEDAR), a platform developed to address the challenge of accurately

doi.org·24d ago

Alp Bio's AI platform predicts immune reactions to biologic drugs earlier in development

An interview with Christian Vahlensieck, co-founder of Alp Bio, a Swiss startup using an AI-powered platform combined with lab-grown human i

vist.ly·13d ago

Alp Bio's AI platform predicts immune reactions to biologic drugs in early development

An interview with Christian Vahlensieck, co-founder of Alp Bio, a Swiss startup using an AI-powered platform combined with lab-grown human i

vist.ly·16d ago

AI-guided discovery identifies GPNMB as promising CAR T cell target for multiple cancers

Researchers developed an AI-driven framework for discovering CAR T cell therapy targets by integrating single-cell RNA sequencing data from

cell.com·14d ago